IS5260A - Dissolved sertraline formulations - Google Patents
Dissolved sertraline formulationsInfo
- Publication number
- IS5260A IS5260A IS5260A IS5260A IS5260A IS 5260 A IS5260 A IS 5260A IS 5260 A IS5260 A IS 5260A IS 5260 A IS5260 A IS 5260A IS 5260 A IS5260 A IS 5260A
- Authority
- IS
- Iceland
- Prior art keywords
- formulations
- dissolved sertraline
- sertraline
- dissolved
- sertraline formulations
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical compound C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 title 1
- 229960002073 sertraline Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5141397P | 1997-07-01 | 1997-07-01 | |
| PCT/IB1998/000933 WO1999001120A1 (en) | 1997-07-01 | 1998-06-15 | Solubilized sertraline compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS5260A true IS5260A (en) | 1999-11-19 |
Family
ID=21971159
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS5260A IS5260A (en) | 1997-07-01 | 1999-11-19 | Dissolved sertraline formulations |
Country Status (34)
| Country | Link |
|---|---|
| EP (1) | EP0999829A1 (en) |
| JP (1) | JP2000514100A (en) |
| KR (1) | KR100366373B1 (en) |
| CN (1) | CN1261794A (en) |
| AP (1) | AP1192A (en) |
| AR (3) | AR015917A1 (en) |
| AU (1) | AU742535B2 (en) |
| BG (1) | BG103918A (en) |
| BR (1) | BR9810739A (en) |
| CA (1) | CA2290974C (en) |
| CO (1) | CO4940495A1 (en) |
| DZ (1) | DZ2548A1 (en) |
| EA (1) | EA002481B1 (en) |
| HN (1) | HN1998000102A (en) |
| HR (1) | HRP980377A2 (en) |
| HU (1) | HUP0002236A3 (en) |
| ID (1) | ID23429A (en) |
| IL (1) | IL133076A (en) |
| IS (1) | IS5260A (en) |
| MA (1) | MA24587A1 (en) |
| NO (1) | NO996520L (en) |
| OA (1) | OA11243A (en) |
| PA (1) | PA8454301A1 (en) |
| PE (1) | PE97199A1 (en) |
| PL (1) | PL337804A1 (en) |
| SK (1) | SK181099A3 (en) |
| TN (1) | TNSN98124A1 (en) |
| TR (1) | TR199903297T2 (en) |
| TW (1) | TW550087B (en) |
| UA (1) | UA67741C2 (en) |
| UY (1) | UY25071A1 (en) |
| WO (1) | WO1999001120A1 (en) |
| YU (1) | YU68299A (en) |
| ZA (1) | ZA985708B (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GEP20053427B (en) | 1999-12-23 | 2005-01-25 | Pfizer Prod Inc | Pharmaceutical Compositions Providing Enhanced Drug Concentrations |
| US20030086972A1 (en) * | 2000-08-09 | 2003-05-08 | Appel Leah E. | Hydrogel-driven drug dosage form |
| JP2004507502A (en) | 2000-08-30 | 2004-03-11 | ファイザー・プロダクツ・インク | Sustained release formulation for growth hormone secretagogue |
| US20040191207A1 (en) * | 2003-03-31 | 2004-09-30 | Lipari John M. | Alpha-hydroxy acid ester drug delivery compositions and methods of use |
| ES2439582T3 (en) * | 2007-03-12 | 2014-01-23 | Dsm Ip Assets B.V. | Cosmetic compositions |
| CA2771403C (en) | 2009-08-19 | 2015-02-24 | Eisai R&D Management Co. Ltd. | Quinoline derivative-containing pharmaceutical composition |
| CN102711763A (en) * | 2009-12-29 | 2012-10-03 | 兴和株式会社 | Pharmaceutical composition for oral administration |
| EP2520299A1 (en) * | 2009-12-29 | 2012-11-07 | Kowa Co., Ltd. | Solid pharmaceutical composition for oral administration |
| CN109908354A (en) * | 2017-12-12 | 2019-06-21 | 万特制药(海南)有限公司 | Sertraline hydrochloride takes orally concentrate and its preparation process |
| CN114894736B (en) * | 2022-05-20 | 2025-03-21 | 中化地质矿山总局地质研究院 | A method for determining nitrate in chloride-type brine |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4803076A (en) * | 1986-09-04 | 1989-02-07 | Pfizer Inc. | Controlled release device for an active substance |
| ATE96999T1 (en) * | 1989-08-30 | 1993-11-15 | Pfizer | USE OF SERTRALINE TO TREAT CHEMICAL ADDICTION. |
| ZA97976B (en) * | 1996-04-05 | 1997-08-18 | Alza Corp | Uniform drug delivery theraphy. |
-
1998
- 1998-06-15 HU HU0002236A patent/HUP0002236A3/en unknown
- 1998-06-15 JP JP11506774A patent/JP2000514100A/en active Pending
- 1998-06-15 SK SK1810-99A patent/SK181099A3/en unknown
- 1998-06-15 PL PL98337804A patent/PL337804A1/en unknown
- 1998-06-15 TR TR1999/03297T patent/TR199903297T2/en unknown
- 1998-06-15 ID IDW991701A patent/ID23429A/en unknown
- 1998-06-15 YU YU68299A patent/YU68299A/en unknown
- 1998-06-15 CN CN98806763A patent/CN1261794A/en active Pending
- 1998-06-15 AU AU75448/98A patent/AU742535B2/en not_active Ceased
- 1998-06-15 BR BR9810739-9A patent/BR9810739A/en not_active Application Discontinuation
- 1998-06-15 EP EP98923019A patent/EP0999829A1/en not_active Withdrawn
- 1998-06-15 IL IL13307698A patent/IL133076A/en not_active IP Right Cessation
- 1998-06-15 KR KR10-1999-7011361A patent/KR100366373B1/en not_active Expired - Fee Related
- 1998-06-15 WO PCT/IB1998/000933 patent/WO1999001120A1/en not_active Ceased
- 1998-06-15 EA EA199900962A patent/EA002481B1/en unknown
- 1998-06-15 UA UA99116391A patent/UA67741C2/en unknown
- 1998-06-15 CA CA002290974A patent/CA2290974C/en not_active Expired - Fee Related
- 1998-06-25 TW TW087110267A patent/TW550087B/en active
- 1998-06-25 AP APAP/P/1998/001280A patent/AP1192A/en active
- 1998-06-26 PE PE1998000573A patent/PE97199A1/en not_active Application Discontinuation
- 1998-06-29 AR ARP980103146A patent/AR015917A1/en not_active Application Discontinuation
- 1998-06-29 UY UY25071A patent/UY25071A1/en not_active IP Right Cessation
- 1998-06-29 PA PA19988454301A patent/PA8454301A1/en unknown
- 1998-06-30 DZ DZ980158A patent/DZ2548A1/en active
- 1998-06-30 TN TNTNSN98124A patent/TNSN98124A1/en unknown
- 1998-06-30 MA MA25146A patent/MA24587A1/en unknown
- 1998-06-30 ZA ZA9805708A patent/ZA985708B/en unknown
- 1998-07-01 HR HR60/051,413A patent/HRP980377A2/en not_active Application Discontinuation
- 1998-07-01 HN HN1998000102A patent/HN1998000102A/en unknown
- 1998-07-01 CO CO98037137A patent/CO4940495A1/en unknown
-
1999
- 1999-11-19 IS IS5260A patent/IS5260A/en unknown
- 1999-11-23 BG BG103918A patent/BG103918A/en unknown
- 1999-12-21 OA OA9900301A patent/OA11243A/en unknown
- 1999-12-28 NO NO996520A patent/NO996520L/en not_active Application Discontinuation
-
2003
- 2003-06-19 AR ARP030102179A patent/AR040279A2/en unknown
- 2003-06-19 AR ARP030102180A patent/AR040280A2/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA24473A1 (en) | FORMULATIONS | |
| IS5555A (en) | Selekoxib formulations | |
| ID30031A (en) | AGROKIMIA FORMULATIONS | |
| ID23546A (en) | ZIPRASIDON FORMULATIONS | |
| NO20004240D0 (en) | formulations | |
| ATE224703T1 (en) | EFFORTABLE FORMULATIONS | |
| PT1130966E (en) | ANTIPARASITARY FORMULATIONS | |
| DE59802860D1 (en) | DISINFECTANT | |
| ID25533A (en) | 2-METHYL-TIENO-BENZODIAZEPIN FORMULATION | |
| DK0853945T3 (en) | Liquid gonadotropin-containing formulations | |
| ID23299A (en) | PHARMACEUTICAL FORMULATIONS | |
| DE69828330D1 (en) | Activated Protein C Formulations | |
| DK1109449T3 (en) | Microcapsule formulations | |
| DE69812475T2 (en) | Photoresist composition | |
| NO980546D0 (en) | Pharmaceutical agents | |
| DE69809717D1 (en) | CONCENTRATED DISINFECTANTS | |
| CY2006006I1 (en) | PROTEIN FORMULATIONS | |
| DE69935609D1 (en) | FORMULATIONS CONTAINING CEFUROXIM-AXETIL | |
| ATE232683T1 (en) | MICROCAPSULE FORMULATIONS | |
| DE69800779D1 (en) | Photopolymerizable composition | |
| DE69809633D1 (en) | Photoresist composition | |
| NO995147D0 (en) | contrast agents | |
| ID16781A (en) | PHARMACEUTICAL FORMULATIONS | |
| IS5260A (en) | Dissolved sertraline formulations | |
| NO20002590D0 (en) | Formulations comprising dissolved paroxetine |